# | Title | Journal | Year | Citations |
---|
|
1 | Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy | Current Cancer Therapy Reviews | 2006 | 152 |
2 | Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment | Current Cancer Therapy Reviews | 2011 | 111 |
3 | The Current and Future Therapies for Human Osteosarcoma | Current Cancer Therapy Reviews | 2013 | 51 |
4 | Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma | Current Cancer Therapy Reviews | 2014 | 34 |
5 | Angiogenin as a Molecular Target for the Treatment of Prostate Cancer | Current Cancer Therapy Reviews | 2011 | 29 |
6 | Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting | Current Cancer Therapy Reviews | 2012 | 24 |
7 | Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy | Current Cancer Therapy Reviews | 2009 | 24 |
8 | microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis | Current Cancer Therapy Reviews | 2011 | 22 |
9 | Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment | Current Cancer Therapy Reviews | 2005 | 21 |
10 | Roles of Tumor Microenvironment in Hepatocelluar Carcinoma | Current Cancer Therapy Reviews | 2015 | 21 |
11 | Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS | Current Cancer Therapy Reviews | 2009 | 20 |
12 | Health Benefits of Avicularin in the Medicine Against Cancerous Disorders and other Complications: Biological Importance, Therapeutic Benefit and Analytical Aspects | Current Cancer Therapy Reviews | 2022 | 20 |
13 | IP6 in Cancer Therapy: Past, Present and Future | Current Cancer Therapy Reviews | 2010 | 19 |
14 | Androgen Receptor Coregulatory Proteins as Potential Therapeutic Targets in the Treatment of Prostate Cancer | Current Cancer Therapy Reviews | 2005 | 18 |
15 | Beta-adrenergic Signaling in the Development and Progression of Pulmonary and Pancreatic Adenocarcinoma | Current Cancer Therapy Reviews | 2012 | 18 |
16 | Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct | Current Cancer Therapy Reviews | 2014 | 18 |
17 | Anti-cancer Potential of Phyto-alkaloids: A Prospective Review | Current Cancer Therapy Reviews | 2016 | 16 |
18 | Drug Delivery Approaches for Doxorubicin in the Management of Cancers | Current Cancer Therapy Reviews | 2020 | 15 |
19 | Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy | Current Cancer Therapy Reviews | 2008 | 14 |
20 | Papain Loaded Solid Lipid Nanoparticles for Colorectal Cancer Therapy | Current Cancer Therapy Reviews | 2018 | 14 |
21 | The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy | Current Cancer Therapy Reviews | 2005 | 13 |
22 | Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances | Current Cancer Therapy Reviews | 2010 | 13 |
23 | Targeting Lentiviral Vectors for Cancer Immunotherapy | Current Cancer Therapy Reviews | 2011 | 13 |
24 | Garlic and its Organosulfides as Potential Chemopreventive Agents: A Review | Current Cancer Therapy Reviews | 2005 | 12 |
25 | Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target | Current Cancer Therapy Reviews | 2007 | 12 |
26 | EBV-Associated Tumors: Pathogenetic Insights for Improved Disease Monitoring and Treatment | Current Cancer Therapy Reviews | 2005 | 11 |
27 | Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene | Current Cancer Therapy Reviews | 2006 | 11 |
28 | The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials | Current Cancer Therapy Reviews | 2009 | 11 |
29 | Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin | Current Cancer Therapy Reviews | 2013 | 11 |
30 | Genetics and Epigenetics of Lung Cancer: Mechanisms and Future Perspectives | Current Cancer Therapy Reviews | 2013 | 11 |
31 | Echinococcus granulosus as a Promising Therapeutic Agent against Triplenegative Breast Cancer | Current Cancer Therapy Reviews | 2023 | 11 |
32 | Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications | Current Cancer Therapy Reviews | 2005 | 10 |
33 | Antioxidant Supplements, Genetics and Chemotherapy Outcomes | Current Cancer Therapy Reviews | 2005 | 10 |
34 | Physical Activity and Cancer Prevention: Updating the Evidence. The Role of Oxidative Stress in Carcinogenesis | Current Cancer Therapy Reviews | 2007 | 10 |
35 | Differences and Similarities of Epothilones | Current Cancer Therapy Reviews | 2011 | 10 |
36 | Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer | Current Cancer Therapy Reviews | 2012 | 10 |
37 | Hypoxia and Oxidative Stress in the Pathogenesis of Gynecological Cancers and in Therapeutical Options | Current Cancer Therapy Reviews | 2011 | 10 |
38 | Significant Changes in D2-like Dopamine Gene Receptors Expression Associated with Non- Small -Cell Lung Cancer: Could it be of Potential Use in the Design of Future Therapeutic Strategies? | Current Cancer Therapy Reviews | 2012 | 10 |
39 | Environmental Exposure, and Other Behavioral Risk Factors in Breast Cancer | Current Cancer Therapy Reviews | 2006 | 9 |
40 | Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine | Current Cancer Therapy Reviews | 2010 | 9 |
41 | Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers | Current Cancer Therapy Reviews | 2014 | 9 |
42 | Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance | Current Cancer Therapy Reviews | 2006 | 8 |
43 | DNA Vaccines for Prostate Cancer | Current Cancer Therapy Reviews | 2012 | 8 |
44 | The Cancer Hygiene Hypothesis: From Theory to Therapeutic Helminths | Current Cancer Therapy Reviews | 2019 | 8 |
45 | Chitosan Nanoparticles as a Carrier for Indigofera intricata Plant Extract: Preparation, Characterization and Anticancer Activity | Current Cancer Therapy Reviews | 2019 | 8 |
46 | Inhibitors of the Hedgehog Signal Transduction Pathway | Current Cancer Therapy Reviews | 2005 | 7 |
47 | Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics | Current Cancer Therapy Reviews | 2007 | 7 |
48 | Protein Glycosylation as Marker of Melanoma Progression | Current Cancer Therapy Reviews | 2008 | 7 |
49 | Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS) | Current Cancer Therapy Reviews | 2012 | 7 |
50 | Cancer and Treatment Modalities | Current Cancer Therapy Reviews | 2017 | 7 |